BioPorto Statistics

Total Valuation

BioPorto has a market cap or net worth of DKK 695.63 million. The enterprise value is 647.15 million.

Market Cap	695.63M
Enterprise Value	647.15M

Important Dates

The next estimated earnings date is Thursday, May 8, 2025.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

BioPorto has 454.66 million shares outstanding. The number of shares has increased by 21.12% in one year.

Current Share Class	n/a
Shares Outstanding	454.66M
Shares Change (YoY)	+21.12%
Shares Change (QoQ)	+6.47%
Owned by Insiders (%)	0.47%
Owned by Institutions (%)	0.31%
Float	452.53M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.19
PB Ratio	16.79
P/TBV Ratio	16.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.88
EV / Sales	18.79
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.30

Financial Position

The company has a current ratio of 2.23, with a Debt / Equity ratio of 0.25.

Current Ratio	2.23
Quick Ratio	1.87
Debt / Equity	0.25
Debt / EBITDA	n/a
Debt / FCF	-0.12
Interest Coverage	-134.77

Financial Efficiency

Return on equity (ROE) is -197.60% and return on invested capital (ROIC) is -110.27%.

Return on Equity (ROE)	-197.60%
Return on Assets (ROA)	-75.41%
Return on Invested Capital (ROIC)	-110.27%
Return on Capital Employed (ROCE)	-182.52%
Revenue Per Employee	717,688
Profits Per Employee	-1.71M
Employee Count	48
Asset Turnover	0.47
Inventory Turnover	2.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +4.80% in the last 52 weeks. The beta is 0.93, so BioPorto's price volatility has been similar to the market average.

Beta (5Y)	0.93
52-Week Price Change	+4.80%
50-Day Moving Average	1.47
200-Day Moving Average	1.73
Relative Strength Index (RSI)	55.21
Average Volume (20 Days)	272,698

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BioPorto had revenue of DKK 34.45 million and -82.15 million in losses. Loss per share was -0.19.

Revenue	34.45M
Gross Profit	22.27M
Operating Income	-88.14M
Pretax Income	-90.11M
Net Income	-82.15M
EBITDA	-87.40M
EBIT	-88.14M
Loss Per Share	-0.19

Full Income Statement

Balance Sheet

The company has 32.84 million in cash and 10.24 million in debt, giving a net cash position of 22.61 million or 0.05 per share.

Cash & Cash Equivalents	32.84M
Total Debt	10.24M
Net Cash	22.61M
Net Cash Per Share	0.05
Equity (Book Value)	41.44M
Book Value Per Share	0.09
Working Capital	32.54M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -86.99 million and capital expenditures -1.72 million, giving a free cash flow of -88.71 million.

Operating Cash Flow	-86.99M
Capital Expenditures	-1.72M
Free Cash Flow	-88.71M
FCF Per Share	-0.20

Full Cash Flow Statement

Margins

Gross margin is 64.64%, with operating and profit margins of -255.86% and -238.46%.

Gross Margin	64.64%
Operating Margin	-255.86%
Pretax Margin	-261.58%
Profit Margin	-238.46%
EBITDA Margin	-253.72%
EBIT Margin	-255.86%
FCF Margin	n/a

Dividends & Yields

BioPorto does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-21.12%
Shareholder Yield	-21.12%
Earnings Yield	-11.81%
FCF Yield	-12.75%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a